Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 3, 2008
DOI: 10.2337/db07-1323

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1323v1
57/9/2413    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bar, Y.
Right arrow Articles by Efrat, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bar, Y.
Right arrow Articles by Efrat, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

HES1 IS INVOLVED IN ADAPTATION OF ADULT HUMAN BETA CELLS TO PROLIFERATION IN VITRO

Yael Bar1, Holger A. Russ1, Sarah Knoller1, Limor Ouziel-Yahalom1, and Shimon Efrat1

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, 69978 Tel Aviv, Israel

Objective: UU In vitro expansion of beta cells from adult human islets could solve the tissue shortage for cell-replacement therapy of diabetes. Culture of human islet cells typically results in <16 cell doublings and loss of insulin expression. Using cell-lineage tracing we demonstrated that the expanded cell population included cells derived from beta cells. Understanding the molecular mechanisms involved in beta-cell fate in vitro is crucial for optimizing expansion and redifferentiation of these cells. In the developing pancreas important cell-fate decisions are regulated by NOTCH receptors, which signal through the Hairy and Enhancer of Split (HES) 1 transcriptional regulator. Here we investigated the role of the NOTCH signaling pathway in beta-cell dedifferentiation and proliferation in vitro.

Research Design and Methods: Isolated human islets were dissociated into single cells. Beta cells were genetically labeled using a Cre-loxP system delivered by lentiviruses. Cells were analyzed for changes in expression of components of the NOTCH pathway during the initial weeks in culture. HES1 expression was inhibited by a small hairpin RNA, and the effects on beta-cell phenotype were analyzed.

Results: Human beta-cell dedifferentiation and entrance into the cell cycle in vitro correlated with activation of the NOTCH pathway and dowregulation of the cell cycle inhibitor p57. Inhibition of HES1 expression using small hairpin RNA resulted in significantly reduced beta-cell replication and dedifferentiation.

Conclusions: These findings demonstrate that the NOTCH pathway is involved in determining beta-cell fate in vitro and suggest possible molecular targets for induction of beta-cell redifferentiation following in vitro expansion.


Correspondence: sefrat{at}post.tau.ac.il


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.